Search

Your search keyword '"Nakashima, Koji"' showing total 4 results
Start Over Author "Nakashima, Koji" Journal annals of oncology
4 results on '"Nakashima, Koji"'

1. MO19-3 Subgroup analyses of phase II study of weekly paclitaxel in advanced esophageal cancer that had previously received docetaxel-containing chemotherapy

Author

Nakashima, Koji, primary, Ando, Takayuki, additional, Yoshida, Hiroki, additional, Sakumura, Miho, additional, Nomura, Motoo, additional, Muto, Manabu, additional, Fujii, Hirofumi, additional, Horie, Yoshiki, additional, Takeda, Hiroyuki, additional, Yoshii, Takako, additional, Tahara, Yoshihiro, additional, Katada, Chikatoshi, additional, Yoshimura, Kenichi, additional, Hideki, Ishikawa, additional, and Hosokawa, Ayumu, additional

Published
2023
Full Text
View/download PDF

2. MO5-1 Characteristics of immune-related adverse events in patients with advanced esophageal cancer treated with nivolumab

Author

Nakada, Naokatsu, primary, Ando, Takayuki, additional, Motoo, Iori, additional, Kajiura, Shinya, additional, Fuchino, Mayo, additional, Sakumura, Miho, additional, Nanjo, Sohachi, additional, Mihara, Hiroshi, additional, Fujinami, Haruka, additional, Ogawa, Kohei, additional, Tsukada, Kenichiro, additional, Nakashima, Koji, additional, Hosokawa, Ayumu, additional, and Yasuda, Ichiro, additional

Published
2021
Full Text
View/download PDF

3. MO5-5 Lesion-level response to immune checkpoint inhibitor in patients with advanced gastric cancer and esophageal cancer

Author

Motoo, Iori, primary, Ando, Takayuki, additional, Murayama, Aiko, additional, Kajiura, Shinya, additional, Ogawa, Kohei, additional, Tsukada, Kenichiro, additional, Ueda, Akira, additional, Suzuki, Nobuhiro, additional, Nakada, Naokatsu, additional, Takatori, Shunsuke, additional, Nakashima, Koji, additional, Hosokawa, Ayumu, additional, Fuchino, Mayo, additional, Nanjo, Sohachi, additional, Fujinami, Haruka, additional, and Yasuda, Ichiro, additional

Published
2021
Full Text
View/download PDF

4. Prespecified Subgroup Analyses in WJOG4407G Trial, a Randomized Phase III Trial of MFOLFOX6 Plus Bevacizumab Versus Folfiri Plus Bevacizumab in First-Line Treatment for Metastatic Colorectal Cancer

Author

Hyodo Ichinosuke, Kawakami Kentaro, Hirashima Tomonori, Okabe Michio, Tamura Fumio, Shinozaki Eiji, Boku Narikazu, Suzuki Kazuya, Tamagawa Hiroshi, Yamazaki Kentaro, Morita Satoshi, Ebi Masahide, Otsuji Toshio, Ando Masahiko, Seki Nobuhiko, Yamaguchi Kensei, Takahashi Yasuo, Taku Keisei, Sato Mikio, Nakashima Koji, and Suyama Koichi

Subjects
Oncology, medicine.medical_specialty, Bevacizumab, Colorectal cancer, business.industry, Hematology, medicine.disease, First line treatment, Internal medicine, medicine, FOLFIRI, business, medicine.drug
Published
2014

Catalog

Books, media, physical & digital resources
See catalog results